Buckle up AbbVie, Amgen: Biohaven’s oral CGRP drug is gaining traction in migraine, doctors’ survey shows aliu Fri, 10/22/2021 – 10:37 More: Buckle up AbbVie, Amgen: Biohaven's oral CGRP drug is gaining traction in migraine, doctors’ survey shows Source: fierce
read moreLilly breached a contract by not paying royalties on big-selling diabetes meds, court finds esagonowsky Fri, 10/22/2021 – 10:35 More: Lilly breached a contract by not paying royalties on big-selling diabetes meds, court finds Source: fierce
read moreThe British Medical Association (BMA) has accused the Health Secretary of being “willfully negligent”. More: UK doctors: Renewed COVID response is urgent Source: News
read moreEUA amendments ‘based on the available data and information’ More: US approval for J&J and Moderna COVID-19 boosters Source: News
read moreDupixent significantly reduced itch and skin lesions compared to placebo in the investigational trial setting More: Dupixent hits all endpoints in prurigo nodularis trial Source: News
read moreAlnylam’s Givlaari wins NICE reversal after offering discount for rare genetic liver condition therapy kdunleavy Thu, 10/21/2021 – 11:20 More: Alnylam's Givlaari wins NICE reversal after offering discount for rare genetic liver condition therapy Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals